Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhendan Zhao

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Endocrinology|May 28, 2024
Causal role of immune cells in Hashimoto's thyroiditis: Mendelian randomization studyZhendan Zhao, Yuehua Gao, Xiaoqing Pei, et al.
Cell Death Discovery|December 10, 2021
SPTBN2 regulated by miR-424-5p promotes endometrial cancer progression via CLDN4/PI3K/AKT axisPengling Wang, Ting Liu, Zhendan Zhao, et al.
Frontiers in Oncology|January 10, 2022
EPDR1, Which Is Negatively Regulated by miR-429, Suppresses Epithelial Ovarian Cancer Progression <i>via</i> PI3K/AKT Signaling PathwayZhendan Zhao, Zhiling Wang, Pengling Wang, et al.
Frontiers in Endocrinology|April 8, 2024
Thyroid function and polycystic ovary syndrome: a Mendelian randomization studyZhendan Zhao, Yuehua Gao, Xiaoqing Pei, et al.
The Journal of Gene Medicine|January 28, 2024
miR-451a suppresses the proliferation and migration of high-grade serous ovarian cancer by targeting RAB5A through the Ras/Raf/MEK/ERK pathwayShujie Liu, Kun Wang, Zhendan Zhao, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Endocrinology|May 28, 2024
Causal role of immune cells in Hashimoto's thyroiditis: Mendelian randomization studyZhendan Zhao, Yuehua Gao, Xiaoqing Pei, et al.
Cell Death Discovery|December 10, 2021
SPTBN2 regulated by miR-424-5p promotes endometrial cancer progression via CLDN4/PI3K/AKT axisPengling Wang, Ting Liu, Zhendan Zhao, et al.
Frontiers in Oncology|January 10, 2022
EPDR1, Which Is Negatively Regulated by miR-429, Suppresses Epithelial Ovarian Cancer Progression <i>via</i> PI3K/AKT Signaling PathwayZhendan Zhao, Zhiling Wang, Pengling Wang, et al.
Frontiers in Endocrinology|April 8, 2024
Thyroid function and polycystic ovary syndrome: a Mendelian randomization studyZhendan Zhao, Yuehua Gao, Xiaoqing Pei, et al.
The Journal of Gene Medicine|January 28, 2024
miR-451a suppresses the proliferation and migration of high-grade serous ovarian cancer by targeting RAB5A through the Ras/Raf/MEK/ERK pathwayShujie Liu, Kun Wang, Zhendan Zhao, et al.
Pageof 1